Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrrolate Inhalation Solution for lung hyperinflation in COPD
NCT04155047Phase 4Completed
- Sponsor
- Sunovion
- Start
- Nov 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glycopyrrolate in chronic obstructive pulmonary disease (COPD), sponsored by Sunovion. Started Nov 2019; status: completed.
02
Drugs
glycopyrrolate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04155047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04155047.